# REZDIFFRA
> **NDA217785** · New Drug Application · Sponsor: MADRIGAL · Approved 2024-03-14
## Drug
- **FDA Application Number:** NDA217785
- **Application type:** New Drug Application
- **Brand name:** REZDIFFRA
- **Generic name:** RESMETIROM
- **Active ingredients:** RESMETIROM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MADRIGAL
- **Manufacturer:** Madrigal Pharmaceuticals, Inc.
- **First approval:** 2024-03-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217785)
---
*AI Analytics · CC0 1.0*